159 related articles for article (PubMed ID: 16495578)
1. Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.
Gamage SD; Patton AK; Strasser JE; Chalk CL; Weiss AA
Infect Immun; 2006 Mar; 74(3):1977-83. PubMed ID: 16495578
[TBL] [Abstract][Full Text] [Related]
2. Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.
Gamage SD; Strasser JE; Chalk CL; Weiss AA
Infect Immun; 2003 Jun; 71(6):3107-15. PubMed ID: 12761088
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.
Robinson CM; Sinclair JF; Smith MJ; O'Brien AD
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9667-72. PubMed ID: 16766659
[TBL] [Abstract][Full Text] [Related]
4. A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.
Nawrocki EM; Mosso HM; Dudley EG
Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32358004
[TBL] [Abstract][Full Text] [Related]
5. Different classes of antibiotics differentially influence shiga toxin production.
McGannon CM; Fuller CA; Weiss AA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3790-8. PubMed ID: 20585113
[TBL] [Abstract][Full Text] [Related]
6. Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease.
Zumbrun SD; Melton-Celsa AR; Smith MA; Gilbreath JJ; Merrell DS; O'Brien AD
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2126-33. PubMed ID: 23690602
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
Calderon Toledo C; Rogers TJ; Svensson M; Tati R; Fischer H; Svanborg C; Karpman D
Am J Pathol; 2008 Nov; 173(5):1428-39. PubMed ID: 18832584
[TBL] [Abstract][Full Text] [Related]
8. Role for flagella but not intimin in the persistent infection of the gastrointestinal tissues of specific-pathogen-free chicks by shiga toxin-negative Escherichia coli O157:H7.
Best A; La Ragione RM; Sayers AR; Woodward MJ
Infect Immun; 2005 Mar; 73(3):1836-46. PubMed ID: 15731085
[TBL] [Abstract][Full Text] [Related]
9. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
[TBL] [Abstract][Full Text] [Related]
10. Isolation of Escherichia coli O157:H7 strains that do not produce Shiga toxin from bovine, avian and environmental sources.
Wetzel AN; Lejeune JT
Lett Appl Microbiol; 2007 Nov; 45(5):504-7. PubMed ID: 17908226
[TBL] [Abstract][Full Text] [Related]
11. Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice.
Rahal EA; Kazzi N; Sabra A; Abdelnoor AM; Matar GM
Ann Clin Microbiol Antimicrob; 2011 Sep; 10():34. PubMed ID: 21906403
[TBL] [Abstract][Full Text] [Related]
12. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the anti-terminator Q933 gene as a marker for Escherichia coli O157:H7 with high Shiga toxin production.
Ahmad A; Zurek L
Curr Microbiol; 2006 Oct; 53(4):324-8. PubMed ID: 16972124
[TBL] [Abstract][Full Text] [Related]
14. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
Liu J; Sun Y; Feng SZ
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
[TBL] [Abstract][Full Text] [Related]
15. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.
Malyukova I; Murray KF; Zhu C; Boedeker E; Kane A; Patterson K; Peterson JR; Donowitz M; Kovbasnjuk O
Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G78-92. PubMed ID: 18974311
[TBL] [Abstract][Full Text] [Related]
16. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.
Asahara T; Shimizu K; Nomoto K; Hamabata T; Ozawa A; Takeda Y
Infect Immun; 2004 Apr; 72(4):2240-7. PubMed ID: 15039348
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
[TBL] [Abstract][Full Text] [Related]
18. Production of shiga toxin by a luxS mutant of Escherichia coli O157:H7 in vivo and in vitro.
Jeon B; Itoh K
Microbiol Immunol; 2007; 51(4):391-6. PubMed ID: 17446678
[TBL] [Abstract][Full Text] [Related]
19. Phage types and genotypes of Shiga toxin-Producing Escherichia coli O157 in Finland.
Saari M; Cheasty T; Leino K; Siitonen A
J Clin Microbiol; 2001 Mar; 39(3):1140-3. PubMed ID: 11230443
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins.
Toshima H; Yoshimura A; Arikawa K; Hidaka A; Ogasawara J; Hase A; Masaki H; Nishikawa Y
Appl Environ Microbiol; 2007 Dec; 73(23):7582-8. PubMed ID: 17933918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
